These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9884035)

  • 1. Elevated serum levels of soluble vascular cell adhesion molecule-1 in NIDDM patients with proliferative diabetic retinopathy.
    Yoshizawa M; Nagai Y; Ohsawa K; Ohta M; Yamashita H; Hisada A; Miyamoto I; Miura K; Takamura T; Kobayashi K
    Diabetes Res Clin Pract; 1998 Oct; 42(1):65-70. PubMed ID: 9884035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study.
    Hernández C; Burgos R; Cantón A; García-Arumí J; Segura RM; Simó R
    Diabetes Care; 2001 Mar; 24(3):516-21. PubMed ID: 11289478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble adhesion molecules are not involved in the development of retinopathy in type 2 diabetic patients.
    Boulbou MS; Koukoulis GN; Petinaki EA; Germenis A; Gourgoulianis KI
    Acta Diabetol; 2004 Sep; 41(3):118-22. PubMed ID: 15666579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between circulating vascular cell adhesion molecule-1 and vascular complications in type 2 diabetes mellitus].
    Gu W; Xu X; Zhu Y
    Zhonghua Nei Ke Za Zhi; 2001 Jul; 40(7):456-8. PubMed ID: 11798614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood serum levels of vascular cell adhesion molecule (sVCAM-1), intercellular adhesion molecule (sICAM-1) and endothelial leucocyte adhesion molecule-1 (ELAM-1) in diabetic retinopathy.
    Nowak M; Wielkoszyński T; Marek B; Kos-Kudła B; Swietochowska E; Siemińska L; Kajdaniuk D; Głogowska-Szelag J; Nowak K
    Clin Exp Med; 2008 Sep; 8(3):159-64. PubMed ID: 18791689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy.
    Sasongko MB; Wong TY; Jenkins AJ; Nguyen TT; Shaw JE; Wang JJ
    Diabet Med; 2015 May; 32(5):686-91. PubMed ID: 25407692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of serum concentrations of soluble adhesion molecules in diabetic microangiopathy and macroangiopathy.
    Matsumoto K; Sera Y; Ueki Y; Inukai G; Niiro E; Miyake S
    Diabet Med; 2002 Oct; 19(10):822-6. PubMed ID: 12358868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Effect of intensive insulin treatment.
    Albertini JP; Valensi P; Lormeau B; Aurousseau MH; Ferrière F; Attali JR; Gattegno L
    Diabetes Care; 1998 Jun; 21(6):1008-13. PubMed ID: 9614623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity of diabetic retinopathy is linked to lipoprotein (a) in type 1 diabetic patients.
    Guerci B; Meyer L; Sommer S; George JL; Ziegler O; Drouin P; Angioï-Duprez K
    Diabetes Metab; 1999 Nov; 25(5):412-8. PubMed ID: 10592864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of selected adhesion molecule and proinflammatory cytokine levels in the vitreous body of patients with type 2 diabetes--role of the inflammatory-immune process in the pathogenesis of proliferative diabetic retinopathy.
    Adamiec-Mroczek J; Oficjalska-Młyńczak J
    Graefes Arch Clin Exp Ophthalmol; 2008 Dec; 246(12):1665-70. PubMed ID: 18682976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Barile GR; Chang SS; Park LS; Reppucci VS; Schiff WM; Schmidt AM
    Curr Eye Res; 1999 Sep; 19(3):219-27. PubMed ID: 10487959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma
    Jiang Q; Lyu XM; Yuan Y; Wang L
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28108673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are soluble E-selectin, ICAM-1, and VCAM-1 potential predictors for the development of diabetic retinopathy in young adults, 15-34 years of age? A Swedish prospective cohort study.
    Ekelund C; Dereke J; Nilsson C; Landin-Olsson M
    PLoS One; 2024; 19(6):e0304173. PubMed ID: 38843125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Bone Metabolism Indices and Bone Mineral Density with Diabetic Retinopathy in Elderly Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Inpatient Study in China.
    Zhao X; Huo L; Yu X; Zhang X
    J Diabetes Res; 2021; 2021():8853622. PubMed ID: 33506053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients.
    Gustavsson C; Agardh E; Bengtsson B; Agardh CD
    J Diabetes Complications; 2008; 22(5):309-16. PubMed ID: 18413212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating vascular cell adhesion molecule-1 (VCAM-1) in atherosclerotic NIDDM patients.
    Otsuki M; Hashimoto K; Morimoto Y; Kishimoto T; Kasayama S
    Diabetes; 1997 Dec; 46(12):2096-101. PubMed ID: 9392502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble vascular cell adhesion molecule-1 and soluble E-selectin are associated with micro- and macrovascular complications in Type 1 diabetic patients.
    Soedamah-Muthu SS; Chaturvedi N; Schalkwijk CG; Stehouwer CD; Ebeling P; Fuller JH;
    J Diabetes Complications; 2006; 20(3):188-95. PubMed ID: 16632240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of adhesion molecules in peripheral blood correlat with stages of diabetic retinopathy and may serve as bio markers for microvascular complications.
    Blum A; Pastukh N; Socea D; Jabaly H
    Cytokine; 2018 Jun; 106():76-79. PubMed ID: 29133026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble leucocyte adhesion molecules in diabetic retinopathy stimulate retinal capillary endothelial cell migration.
    Olson JA; Whitelaw CM; McHardy KC; Pearson DW; Forrester JV
    Diabetologia; 1997 Oct; 40(10):1166-71. PubMed ID: 9349597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum sialic acid concentration in NIDDM and its relationship to blood pressure and retinopathy.
    Crook MA; Tutt P; Pickup JC
    Diabetes Care; 1993 Jan; 16(1):57-60. PubMed ID: 8422833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.